CS
ORIAU

Clear Street’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Clear Street’s Portfolio ORIAU Stock Details ORIAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-850
Closed -$8.3K – 1570
2023
Q1 		$8.3K Buy
850
+550
+183% +$5.58K ﹤0.01% 556
2022
Q4 		$3K Sell
300
-1,600
-84% -$15.9K ﹤0.01% 799
2022
Q3 		$19K Buy
+1,900
New +$18.7K ﹤0.01% 496

Clear Street's ORIAU Position: Q2 2023 in Review

Clear Street sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2023, closing a stake of 850 shares — an estimated $8.3K sold.

Clear Street first reported a position in ORIAU in Q3 2022 and held it in 3 quarters. The position peaked at $19K in Q3 2022. 0 funds tracked by Wall St. Rank hold ORIAU as of Q2 2023.

  • Clear Street reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2023 after selling out during the quarter.
  • Clear Street sold 850 Orion Biotech Opportunities Corp. Units shares in Q2 2023, an estimated $8.3K.
  • Clear Street first reported a position in Orion Biotech Opportunities Corp. Units in Q3 2022 and held it in 3 quarters.
  • Clear Street's Orion Biotech Opportunities Corp. Units position peaked at $19K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2023.

Based on Clear Street's 13F filing for Q2 2023, filed 14 Aug 2023.